和邦生物 - Financials

和邦生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
+Revenue	8.5B	8.8B	13.0B	10.0B	5.3B	6.0B	6.0B	4.7B	3.5B	2.9B	2.2B	1.6B	1.7B	1.9B	1.4B	844.0M
Revenue Growth %	-3.1%	-32.3%	30.6%	89.8%	-11.9%	-0.7%	26.8%	36.8%	21.0%	31.0%	36.4%	-7.8%	-8.5%	32.6%	69.8%	--
Total Revenue	8.5B	8.8B	13.0B	10.0B	5.3B	6.0B	6.0B	4.7B	3.5B	2.9B	2.2B	1.6B	1.7B	1.9B	1.4B	844.0M
Cost Of Revenue	7.9B	6.8B	7.5B	5.9B	4.3B	4.6B	4.7B	3.5B	2.6B	2.2B	1.7B	1.3B	1.1B	1.1B	973.0M	645.0M
+Gross Profit	666.0M	2.1B	5.6B	4.1B	989.0M	1.4B	1.3B	1.2B	827.0M	628.0M	459.0M	308.0M	653.0M	807.0M	460.0M	199.0M
Gross Margin %	7.8%	23.3%	42.9%	41.4%	18.8%	22.8%	22.1%	25.4%	23.9%	21.9%	21.0%	19.2%	37.6%	42.5%	32.1%	23.6%
Total Operating Cost	8.6B	7.4B	8.6B	6.4B	4.9B	5.4B	5.6B	4.2B	3.2B	2.7B	2.2B	1.6B	1.4B	1.4B	1.3B	798.0M
Selling Expenses	79.3M	59.6M	52.5M	52.1M	63.9M	290.0M	339.0M	259.0M	245.0M	147.0M	101.0M	81.6M	51.9M	81.6M	131.0M	71.7M
Admin Expenses	415.0M	413.0M	845.0M	312.0M	318.0M	321.0M	263.0M	231.0M	191.0M	133.0M	103.0M	85.6M	102.0M	96.6M	64.6M	60.9M
Rd Expenses	30.6M	47.3M	67.9M	33.3M	39.7M	38.3M	31.1M	34.8M	--	--	--	--	--	--	--	--
Finance Expenses	15.0M	-32.5M	24.1M	84.4M	121.0M	64.4M	79.8M	56.8M	96.8M	123.0M	137.0M	71.4M	108.0M	130.0M	79.9M	18.5M
+Operating Income	-61.8M	1.5B	4.5B	3.6B	440.0M	583.0M	414.0M	596.0M	347.0M	219.0M	679.0M	70.3M	384.0M	487.0M	193.0M	46.5M
Operating Margin %	-0.7%	17.5%	34.4%	36.0%	8.4%	9.8%	6.9%	12.6%	10.0%	7.6%	31.1%	4.4%	22.1%	25.6%	13.5%	5.5%
Non Operating Income	1.1M	3.2M	58,400	3.0M	206,200	1.2M	1.8M	635,000	23.9M	63.9M	712,700	150,800	5.6M	79,300	7.5M	2.2M
Non Operating Expenses	5.0M	9.0M	2.7M	15.7M	425.0M	100,400	91,300	347,600	1.0M	337,500	--	--	100.00	82,000	1.3M	11,000
Investment Income	-5.7M	75.2M	21.8M	27.0M	24.4M	-1.2M	20.4M	36.8M	41.4M	44.5M	663.0M	31.7M	27.4M	18.1M	21.6M	--
Asset Disposal Income	1.2M	808,200	37.1M	-1.0M	6.7M	-2.4M	-3.7M	-768,000	7.7M	--	--	--	--	--	--	--
Asset Impairment Loss	128.0M	36.8M	80.8M	--	6.0M	9.1M	165.0M	29.3M	-41.0M	26.8M	82.3M	8.1M	5.1M	766,700	12.3M	1.2M
Other Income	16.1M	17.5M	31.7M	10.4M	11.1M	10.1M	1.6M	11.5M	--	--	--	--	--	--	--	--
Income Before Tax	-65.7M	1.5B	4.5B	3.6B	15.8M	584.0M	416.0M	596.0M	370.0M	282.0M	679.0M	70.5M	390.0M	487.0M	199.0M	48.8M
Income Tax	5.1M	257.0M	668.0M	552.0M	12.9M	77.1M	117.0M	90.9M	48.1M	43.5M	7.7M	6.1M	54.9M	71.0M	28.4M	5.5M
+Net Income	-70.7M	1.3B	3.8B	3.0B	2.9M	507.0M	298.0M	505.0M	321.0M	239.0M	672.0M	64.4M	335.0M	416.0M	171.0M	43.2M
Net Margin %	-0.8%	14.5%	29.2%	30.3%	0.1%	8.5%	5.0%	10.7%	9.3%	8.3%	30.7%	4.0%	19.3%	21.9%	11.9%	5.1%
Net Income Attributable	31.5M	1.3B	3.8B	3.0B	40.9M	517.0M	363.0M	518.0M	318.0M	240.0M	672.0M	64.4M	335.0M	416.0M	173.0M	44.2M
Minority Interest	-102.0M	-4.5M	3.4M	8.0M	-38.0M	-10.2M	-64.9M	-12.3M	3.7M	-1.1M	--	-8,200	--	--	-2.1M	-933,100
Eps Basic	0.00	0.15	0.44	0.36	0.00	0.06	0.04	0.06	0.04	0.07	0.23	0.07	0.86	1.19	0.58	0.15
Eps Diluted	0.00	0.15	0.44	0.36	0.00	0.06	0.04	0.06	0.04	0.07	0.23	0.07	0.86	1.19	0.58	0.15

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash And Equivalents	7.0B	3.1B	4.6B	1.7B	846.0M	591.0M	1.3B	831.0M	309.0M	569.0M	146.0M	309.0M	1.4B	358.0M	112.0M	348.0M
Trading Financial Assets	--	--	--	56.9M	--	206.0M	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	810.0M	978.0M	778.0M	498.0M	519.0M	535.0M	469.0M	700.0M	636.0M	628.0M	467.0M	301.0M	155.0M	65.1M	57.4M	60.8M
Notes Receivable	--	--	--	--	3.8M	--	250.0M	886.0M	254.0M	120.0M	75.9M	445.0M	243.0M	217.0M	161.0M	80.9M
Notes And Accounts Receivable	810.0M	978.0M	778.0M	498.0M	523.0M	535.0M	719.0M	1.6B	890.0M	748.0M	543.0M	746.0M	399.0M	282.0M	218.0M	142.0M
Prepayments	205.0M	191.0M	195.0M	128.0M	133.0M	168.0M	300.0M	67.3M	76.9M	119.0M	119.0M	69.5M	149.0M	43.6M	234.0M	153.0M
Inventory	4.5B	4.4B	2.1B	912.0M	633.0M	1.3B	1.1B	1.1B	864.0M	821.0M	902.0M	548.0M	449.0M	229.0M	163.0M	82.5M
Total Current Assets	14.0B	9.9B	9.7B	4.6B	3.3B	3.5B	3.5B	3.6B	3.6B	2.3B	1.8B	1.7B	2.4B	923.0M	727.0M	727.0M
Long Term Equity Investment	51.1M	--	201.0M	181.0M	169.0M	160.0M	156.0M	203.0M	209.0M	179.0M	140.0M	271.0M	298.0M	291.0M	252.0M	30.0M
Fixed Assets	--	8.5B	7.6B	7.7B	5.2B	5.1B	4.5B	4.8B	4.2B	3.4B	2.9B	1.5B	1.6B	1.8B	1.9B	845.0M
Fixed Assets Total	7.6B	8.5B	7.6B	7.7B	5.2B	5.1B	4.5B	4.8B	4.2B	3.4B	2.9B	1.5B	1.6B	1.8B	1.9B	845.0M
Construction In Progress	--	1.2B	1.8B	533.0M	2.3B	2.1B	1.8B	922.0M	1.2B	1.7B	1.7B	696.0M	128.0M	21.8M	54.3M	1.4B
Construction In Progress Total	2.4B	1.2B	1.9B	534.0M	2.3B	2.1B	1.9B	925.0M	1.2B	1.7B	1.7B	821.0M	132.0M	21.8M	54.3M	1.4B
Intangible Assets	2.4B	2.2B	2.1B	2.0B	1.0B	1.1B	1.1B	1.1B	1.0B	966.0M	883.0M	793.0M	646.0M	649.0M	160.0M	134.0M
Long Term Deferred Expenses	1.2M	4.9M	6.1M	7.3M	9.8M	9.7M	22,300	172,800	203,900	--	--	--	--	--	--	--
Total Non Current Assets	15.6B	14.7B	14.4B	13.3B	11.4B	11.0B	9.8B	9.5B	9.3B	8.9B	7.3B	3.9B	2.7B	2.7B	2.4B	2.4B
Total Assets	29.6B	24.5B	24.1B	17.9B	14.7B	14.5B	13.3B	13.1B	12.9B	11.2B	9.1B	5.6B	5.0B	3.7B	3.1B	3.2B
Short Term Borrowings	2.4B	1.2B	1.2B	1.2B	1.6B	1.6B	850.0M	420.0M	442.0M	2.6B	1.6B	655.0M	330.0M	530.0M	650.0M	807.0M
Accounts Payable	1.4B	1.5B	1.8B	1.2B	1.0B	971.0M	743.0M	697.0M	671.0M	786.0M	802.0M	265.0M	149.0M	294.0M	283.0M	365.0M
Advance Receipts	--	--	--	--	--	74.8M	63.0M	79.2M	104.0M	103.0M	55.5M	34.6M	67.9M	69.3M	43.3M	53.3M
Contract Liabilities	45.1M	95.3M	234.0M	370.0M	112.0M	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	5.4B	3.7B	3.7B	3.1B	3.2B	2.8B	1.8B	1.3B	1.3B	3.7B	3.4B	1.5B	896.0M	1.1B	1.1B	1.3B
Long Term Borrowings	766.0M	431.0M	408.0M	68.1M	262.0M	226.0M	180.0M	--	--	70.0M	210.0M	410.0M	745.0M	1.2B	1.0B	1.1B
Total Non Current Liabilities	5.3B	654.0M	605.0M	162.0M	281.0M	246.0M	328.0M	516.0M	821.0M	894.0M	1.0B	806.0M	746.0M	1.2B	1.0B	1.1B
Total Liabilities	10.6B	4.3B	4.3B	3.3B	3.4B	3.0B	2.1B	1.8B	2.2B	4.6B	4.4B	2.3B	1.6B	2.3B	2.1B	2.4B
Paid In Capital	8.8B	8.8B	8.8B	8.8B	8.8B	8.8B	8.8B	8.8B	4.0B	3.3B	1.0B	450.0M	450.0M	350.0M	350.0M	300.0M
Capital Reserve	1.0B	1.1B	1.1B	470.0M	213.0M	213.0M	213.0M	213.0M	4.2B	1.1B	2.0B	1.7B	1.7B	154.0M	167.0M	7.8M
Surplus Reserve	600.0M	590.0M	488.0M	349.0M	226.0M	187.0M	172.0M	170.0M	150.0M	129.0M	123.0M	123.0M	118.0M	86.4M	47.3M	46.5M
Retained Earnings	9.5B	9.6B	8.8B	5.3B	2.4B	2.4B	1.9B	1.7B	2.0B	1.8B	1.6B	969.0M	1.1B	786.0M	410.0M	294.0M
Minority Equity	380.0M	643.0M	645.0M	392.0M	166.0M	220.0M	227.0M	287.0M	319.0M	295.0M	--	--	--	--	--	89.6M
Equity Attributable	18.6B	19.6B	19.1B	14.2B	11.1B	11.2B	11.0B	11.0B	10.5B	6.3B	4.8B	3.3B	3.4B	1.4B	975.0M	648.0M
Total Equity	19.0B	20.2B	19.8B	14.6B	11.3B	11.5B	11.2B	11.3B	10.8B	6.6B	4.8B	3.3B	3.4B	1.4B	975.0M	738.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009
Cash From Sales	7.5B	6.0B	9.1B	8.1B	3.2B	3.4B	4.6B	2.9B	3.2B	2.7B	1.7B	1.1B	1.5B	1.7B	1.1B	694.0M
Tax Refunds Received	37.2M	331.0M	188.0M	3.4M	3.2M	4.5M	14.4M	15.6M	17.6M	2.8M	--	--	--	--	--	--
Total Operating Cash Inflow	7.7B	6.4B	9.4B	8.1B	3.3B	3.4B	4.7B	3.0B	3.2B	2.8B	1.7B	1.1B	1.5B	1.7B	1.1B	699.0M
Cash Paid For Goods	5.8B	4.9B	4.5B	3.4B	2.2B	2.4B	2.7B	2.0B	2.0B	1.8B	1.1B	1.2B	928.0M	718.0M	538.0M	439.0M
Cash Paid To Employees	884.0M	731.0M	586.0M	456.0M	321.0M	297.0M	304.0M	288.0M	227.0M	197.0M	112.0M	107.0M	114.0M	103.0M	89.5M	95.1M
Taxes Paid	345.0M	531.0M	1.6B	912.0M	225.0M	250.0M	317.0M	217.0M	213.0M	159.0M	85.7M	70.9M	203.0M	186.0M	36.3M	27.0M
Total Operating Cash Outflow	7.2B	6.4B	6.8B	4.8B	2.9B	3.3B	3.7B	2.8B	2.7B	2.4B	1.5B	1.5B	1.3B	1.1B	792.0M	630.0M
Operating Cash Flow	468.0M	80.3M	2.6B	3.3B	369.0M	163.0M	944.0M	177.0M	575.0M	449.0M	205.0M	-407.0M	135.0M	553.0M	331.0M	69.0M
Total Investing Cash Inflow	45.6M	280.0M	130.0M	76.3M	342.0M	363.0M	133.0M	1.5B	134.0M	248.0M	89.5M	1.0B	30.3M	420,000	154.0M	--
Total Investing Cash Outflow	1.4B	1.1B	937.0M	1.9B	552.0M	1.6B	453.0M	694.0M	2.3B	1.5B	702.0M	1.9B	274.0M	377.0M	785.0M	869.0M
Investing Cash Flow	-1.4B	-782.0M	-807.0M	-1.8B	-210.0M	-1.3B	-320.0M	795.0M	-2.2B	-1.3B	-612.0M	-899.0M	-244.0M	-376.0M	-631.0M	-869.0M
Cash From Borrowings	8.0B	1.8B	1.8B	1.3B	1.9B	1.7B	2.2B	1.9B	2.0B	4.1B	1.8B	855.0M	425.0M	976.0M	880.0M	1.7B
Dividends And Interest Paid	247.0M	464.0M	198.0M	78.0M	92.7M	71.1M	253.0M	110.0M	198.0M	379.0M	215.0M	274.0M	123.0M	121.0M	126.0M	147.0M
Debt Repayments	1.5B	1.7B	1.3B	2.1B	1.6B	1.1B	1.9B	2.3B	4.3B	3.8B	1.8B	708.0M	901.0M	782.0M	927.0M	840.0M
Total Financing Cash Inflow	8.1B	1.9B	2.5B	1.8B	1.9B	1.8B	2.2B	1.9B	5.9B	5.5B	2.2B	1.3B	2.1B	976.0M	1.1B	1.8B
Total Financing Cash Outflow	3.3B	2.8B	1.5B	2.4B	1.9B	1.4B	2.3B	2.4B	4.5B	4.3B	2.0B	1.0B	1.0B	906.0M	1.1B	987.0M
Financing Cash Flow	4.8B	-944.0M	1.0B	-619.0M	78.4M	367.0M	-160.0M	-447.0M	1.3B	1.2B	262.0M	239.0M	1.1B	70.4M	67.8M	815.0M
Net Change In Cash	3.9B	-1.6B	2.9B	844.0M	263.0M	-737.0M	500.0M	502.0M	-260.0M	429.0M	-145.0M	-1.1B	994.0M	246.0M	-233.0M	15.4M
Ending Cash Balance	6.9B	2.9B	4.5B	1.7B	837.0M	574.0M	1.3B	811.0M	309.0M	569.0M	139.0M	285.0M	1.4B	358.0M	112.0M	344.0M
Capex	1.1B	829.0M	936.0M	1.8B	197.0M	663.0M	364.0M	509.0M	677.0M	1.1B	717.0M	599.0M	274.0M	345.0M	571.0M	849.0M